(Q37862763)

24 August 2017

1 reference

title

Coverage with evidence development: the Ontario experience (English)

1 reference

24 August 2017

7

1 reference

24 August 2017

Murray Krahn

4

0 references

author name string

Leslie Levin

1

1 reference

24 August 2017

Ron Goeree

2

1 reference

24 August 2017

Mark Levine

3

1 reference

24 August 2017

Tony Easty

5

1 reference

24 August 2017

Adalstein Brown

6

1 reference

24 August 2017

1 April 2011

1 reference

International Journal of Technology Assessment in Health Care

24 August 2017

1 reference

24 August 2017

27

1 reference

24 August 2017

2

1 reference

24 August 2017

159-168

1 reference

Positron emission tomography in staging early lung cancer: a randomized trial.

24 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

Long-Term Cost-utility Analysis of a Multidisciplinary Primary Care Diabetes Management Program in Ontario

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

7 January 2021

Value based pricing for NHS drugs: an opportunity not to be missed?

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

7 January 2021

Building bridges between academic research and policy formulation: the PRUFE framework - an integral part of Ontario's evidence-based HTPA process

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

7 January 2021

Effectiveness and safety of drug-eluting stents in Ontario.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

7 January 2021

Comparative effectiveness research and evidence-based health policy: experience from four countries

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

7 January 2021

Comparative effectiveness research in Ontario, Canada: producing relevant and timely information for health care decision makers

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

7 January 2021

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

7 January 2021

Evidence-based approach to the introduction of positron emission tomography in ontario, Canada

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

7 January 2021

Establishing a comprehensive continuum from an evidentiary base to policy development for health technologies: the Ontario experience

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

7 January 2021

Medicare and medical technology--the growing demand for relevant outcomes

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

7 January 2021

Cost-effectiveness analysis of elective endovascular repair compared with open surgical repair of abdominal aortic aneurysms for patients at a high surgical risk: A 1-year patient-level analysis conducted in Ontario, Canada

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

7 January 2021

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

7 January 2021

Coverage options for promising technologies: Medicare's 'coverage with evidence development'

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

7 January 2021

Grading quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

7 January 2021

Health technology assessment: a comprehensive framework for evidence-based recommendations in Ontario

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

7 January 2021

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

7 January 2021

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000018

7 January 2021

10.1017/S0266462311000018

Identifiers

DOI

1 reference

24 August 2017

1 reference